Lumos Pharma Inc.
12/12/2024 | Press release | Distributed by Public on 12/13/2024 05:05
Notice of Effectiveness (Form EFFECT)
Notice of Effectiveness
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 12, 2024 |
| Accession Number: | 0001193125-24-276553 | |||||
| Submission Type: | POS AM | |||||
|